The difference primarily lies in the absorption speed and method, not the benefits themselves
Standard / Gradual Approach The escalation used in REDEFINE mirrors the standard semaglutide ladder, applied to both peptides at once: start at 0.25 mg of each per week and roughly double the step every four weeks toward a 2.4 mg + 2.4 mg weekly target [1]
The official text is published by WADA in English and French
In a trial of patients with T2DM and BMI 27 kg/m2 or more receiving semaglutide injection for weight management, retinal disorders were reported by 6.9% of patients treated with semaglutide 2.4 mg/week, 6.2% of patients treated with semaglutide 1 mg/week, and 4.2% of patients treated with placebo
Vukojevic et al., 2020), bypassing the occlusion (Vukojevic et al., 2018
Ann Agric Environ Med 2004;11:309317